none

CSIRO IS ON A HEALTH KICK

05-09-2017
by 
in 
CSIRO M2 programme

Breakthroughs and remarkable discoveries are expected from the new "M2" programme between CSIRO and Monash University, as the two scientific behemoths collaborate to "bring the best minds and technology together to turn great ideas into a reality for Australia’s flourishing medtech industry". 

As innovation continues to be the watchword for Australian industry, efforts by the government to reinvest in science and technology are continuing apace. 

“From life-changing cochlear implants, to life-saving vaccines, world-first 3D printed bone and tissue replacements, Australia has an incredible track record when it comes to medical technologies and pharmaceuticals,” Senator Arthur Sinodinos said.

“M2 will help to accelerate development of technology like this, not only vital for the improvement of the lives of Australians facing medial challenges, but also leading to job and economic growth for Australia.”

Supported by the Science and Industry Endowment fund, M2 aims to bridge the gap between Australia's many small- and medium-sized medical technology enterprises, and the often-exorbitant cost of prototyping and developing new products. 

M2 will be providing a research ecosystem for these companies, helping to transition new discoveries from the bench to prototyping, pre-clinical testing, industry evaluation and commercialisation.

“M2 leverages some of Australia’s best medtech expertise, experience and equipment,” CSIRO Director of Manufacturing Dr Keith McLean said.

“When a company comes to us we can use CSIRO and MHTP facilities to develop and analyse production scale prototypes, whilst the Monash Biomedical Imaging facility can provide advanced pre-clinical and clinical testing and imaging.”

With global populations ageing and emerging markets seeking better health care, there’s huge growth underway in the MTP sector. It’s expected to be worth almost $3 trillion by 2025, while $18 billion and 28,000 new jobs could be added to the Australian economy over the next eight years.

“Monash is determined to help build a new, globally competitive biomedical industry with our partners,” Monash University Provost and Senior Vice-President Professor Marc Parlange said.

“This initiative will deliver real health benefits to all Australians. Our healthcare spending is expected to almost double to 16 per cent of GDP by 2040. Cheaper and more effective medical solutions are better for our health and Australia’s financial future.”

Related news & editorials

  1. 23.07.2019
    23.07.2019
    by      In
    Tyre recycler Green Distillation Technologies is set to conduct the first industrial trials of revolutionary new thermoelectric technology from the USA.
    The devices fit around an exhaust flue and convert waste heat to electric energy. To date, prototype testing has been confined to the US... Read More
  2. 22.07.2019
    22.07.2019
    by      In
    Engineers are constantly seeking strong, lightweight materials for use in cars, planes and other vehicles to improve aerodynamics, speed, fuel efficiency and weight load. A world-first study by researchers from Monash University, Chongqing University (China) and the CSIRO has discovered a technique... Read More
  3. 19.07.2019
    19.07.2019
    by      In
    CEBIT Australia is Asia Pacific’s largest and longest running business and technology exhibition and conference. Some of the nation’s most influential leaders will take part in CEBIT Australia 2019, at Sydney’s International Convention Centre from 29th to 31st October. Tickets for one- and three-... Read More
  4. 18.07.2019
    18.07.2019
    by      In
    High-tech developer Micro-X will bring the design and manufacture of its next generation of carbon nanotube X-ray tubes to the Tonsley innovation district in the southern suburbs of Adelaide, in order to give it greater control over its operations.
    Micro-X has achieved strong growth since the 2017... Read More